Fevertree Drinks (LON:FEVR - Get Free Report) had its target price lowered by investment analysts at Deutsche Bank Aktiengesellschaft from GBX 900 to GBX 870 in a report issued on Tuesday, Digital Look reports. The firm presently has a "hold" rating on the stock. Deutsche Bank Aktiengesellschaft's target price indicates a potential upside of 5.71% from the company's current price.
Other equities research analysts have also issued research reports about the company. Jefferies Financial Group raised their target price on Fevertree Drinks from GBX 1,080 to GBX 1,100 and gave the stock a "buy" rating in a research report on Thursday, July 30th. Berenberg Bank reaffirmed a "hold" rating and issued a GBX 780 price target on shares of Fevertree Drinks in a report on Monday, September 14th. One investment analyst has rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of GBX 912.50.
View Our Latest Report on FEVR
Fevertree Drinks Stock Performance
Shares of FEVR stock opened at GBX 823 on Tuesday. The company has a current ratio of 3.16, a quick ratio of 3.21 and a debt-to-equity ratio of 1.89. The firm has a fifty day moving average price of GBX 841.92 and a 200 day moving average price of GBX 815.47. The company has a market cap of £917.69 million, a P/E ratio of 38.75, a PEG ratio of -4.51 and a beta of 1.14. Fevertree Drinks has a 12 month low of GBX 711 and a 12 month high of GBX 973.
Fevertree Drinks (LON:FEVR - Get Free Report) last posted its quarterly earnings results on Thursday, September 10th. The company reported GBX 9.50 earnings per share for the quarter. Fevertree Drinks had a return on equity of 11.88% and a net margin of 7.29%. Sell-side analysts predict that Fevertree Drinks will post 38.3184173 earnings per share for the current fiscal year.
Insider Buying and Selling at Fevertree Drinks
In other Fevertree Drinks news, insider Domenico De Lorenzo bought 44,674 shares of the firm's stock in a transaction dated Friday, September 11th. The stock was acquired at an average price of GBX 780 per share, for a total transaction of £348,457.20. Company insiders own 13.09% of the company's stock.
Fevertree Drinks Company Profile
(
Get Free Report)
Fevertree Drinks PLC, together with its subsidiaries, engages in the development and sale of premium mixer drinks in the United Kingdom, the United States, rest of Europe, and internationally. It offers Indian, Mediterranean, summer garden, elderflower, cucumber, damson and sloe berry, rhubarb and raspberry, aromatic, lemon, and Clementine tonic water products; pink grapefruit, soda water, raspberry and orange blossom, Mexican lime, Italian blood orange, white grape and apricot sodas; Silician, premium, and Madagascan cola and lemonades; British apple with garden mint, ginger, Sicilian lemonade, sparkling Mexican lime, Italian white grape and apricot, and light raspberry and rose lemonade softdrinks; and gingers.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Fevertree Drinks, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fevertree Drinks wasn't on the list.
While Fevertree Drinks currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.